A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan wins 1 silver, 4 bronze at 2025 Asian Athletics Championships
05/31/2025 09:35 PM - Society
World Masters Games closing lyric muting draws public backlash
05/31/2025 09:25 PM - Society
Vietnamese man dies after falling into concrete pit at Miaoli factory
05/31/2025 08:11 PM - Society
Missing U.S. tourist found dead after being swept out to sea
05/31/2025 07:46 PM - Society
Taiwan suspends Haribo gummy imports over cannabis contamination concerns
05/31/2025 06:59 PM